Hyun Ah Kim Selected Research

Pep-1 peptide

1/2017	PEP-1-GRX-1 Modulates Matrix Metalloproteinase-13 and Nitric Oxide Expression of Human Articular Chondrocytes.
7/2015	PEP-1-FK506BP12 inhibits matrix metalloproteinase expression in human articular chondrocytes and in a mouse carrageenan-induced arthritis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyun Ah Kim Research Topics

Disease

20	Hypoxia (Hypoxemia) 07/2020 - 08/2007
15	Ischemic Stroke 01/2024 - 08/2012
15	Stroke (Strokes) 01/2024 - 01/2012
15	Rheumatoid Arthritis 01/2022 - 12/2005
13	Neoplasms (Cancer) 03/2024 - 01/2008
13	Osteoarthritis 01/2021 - 02/2005
12	COVID-19 07/2023 - 01/2020
12	Infarction (Infarctions) 01/2023 - 08/2012
11	Inflammation (Inflammations) 01/2024 - 01/2014
10	Pain (Aches) 12/2023 - 02/2005
8	Infections 04/2024 - 07/2012
8	Ischemia 07/2021 - 01/2008
8	Brain Ischemia (Cerebral Ischemia) 01/2019 - 07/2009
6	Pneumonia (Pneumonitis) 01/2022 - 09/2013
6	Arthritis (Polyarthritis) 10/2016 - 11/2003
5	Hypertension (High Blood Pressure) 01/2024 - 11/2015
5	Knee Osteoarthritis 01/2023 - 02/2005
5	Edema (Dropsy) 11/2018 - 11/2012
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2013 - 10/2010
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 03/2014
4	Glioblastoma (Glioblastoma Multiforme) 11/2015 - 11/2013
3	Body Weight (Weight, Body) 05/2024 - 04/2009
3	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 02/2015
3	Brain Injuries (Brain Injury) 01/2023 - 01/2018
3	Lung Diseases (Lung Disease) 05/2022 - 04/2010
3	Gout 10/2021 - 08/2014
3	Neuroinflammatory Diseases 01/2020 - 03/2014
3	Huntington Disease (Huntington's Disease) 04/2015 - 09/2011
2	Liver Abscess 04/2024 - 01/2015
2	Fibrosis (Cirrhosis) 01/2024 - 10/2010
2	Cognitive Dysfunction 01/2024 - 10/2012
2	Neutropenia 01/2023 - 10/2018
2	Communicable Diseases (Infectious Diseases) 01/2023 - 12/2020
2	Pyelonephritis 08/2022 - 02/2022
2	Severe Fever with Thrombocytopenia Syndrome 01/2021 - 07/2017
2	Fever (Fevers) 12/2020 - 09/2013
2	Ankylosing Spondylitis 08/2020 - 12/2005
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2017 - 12/2009
2	Bursitis (Adhesive Capsulitis) 04/2016 - 02/2005

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2006
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015 - 01/2008
9	C-Reactive ProteinIBA 07/2023 - 12/2005
7	Oxygen (Dioxygen)IBA 06/2022 - 08/2007
7	Erythropoietin FDA Link 11/2015 - 08/2007
6	Messenger RNA (mRNA)IBA 01/2020 - 08/2007
6	CytokinesIBA 05/2019 - 03/2014
5	Fibronectins (Fibronectin)IBA 01/2021 - 11/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2007
4	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2013
4	salicylhydroxamic acid (SHAM)IBA 01/2020 - 05/2017
4	tocilizumab (atlizumab)FDA Link 07/2019 - 01/2015
4	Peptides (Polypeptides)IBA 12/2015 - 05/2012
4	LuciferasesIBA 11/2013 - 08/2007
3	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 04/2009
3	LipidsIBA 01/2024 - 04/2009
3	Angiotensin IIIBA 01/2024 - 11/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 02/2005
3	Dexamethasone (Maxidex)FDA LinkGeneric 05/2022 - 11/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 07/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2020 - 10/2012
3	Vitamin D FDA LinkGeneric 04/2020 - 01/2018
3	Immunoglobulin G (IgG)IBA 03/2019 - 12/2005
3	CholesterolIBA 01/2019 - 06/2008
3	Neuroprotective AgentsIBA 01/2018 - 08/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2017 - 01/2010
3	AntibodiesIBA 10/2016 - 12/2005
3	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2016 - 03/2014
3	PolymersIBA 12/2015 - 10/2013
3	Arginine (L-Arginine)FDA Link 12/2015 - 04/2010
3	Dopamine Receptors (Dopamine Receptor)IBA 04/2015 - 09/2011
3	LipopolysaccharidesIBA 02/2015 - 11/2011
3	Celecoxib (Celebrex)FDA Link 11/2014 - 05/2007
3	PolyethyleneimineIBA 03/2014 - 01/2009
3	Heme Oxygenase-1IBA 10/2013 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2020
2	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 01/2021
2	regdanvimabIBA 01/2023 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2015
2	CreatinineIBA 06/2022 - 01/2020
2	SteroidsIBA 05/2022 - 01/2021
2	Uric Acid (Urate)IBA 10/2021 - 12/2015
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 01/2018
2	Methotrexate (Mexate)FDA LinkGeneric 07/2019 - 05/2017
2	Antirheumatic Agents (DMARD)IBA 07/2019 - 12/2006
2	Phosphotransferases (Kinase)IBA 05/2019 - 03/2014
2	Interleukin-1 (Interleukin 1)IBA 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 12/2018 - 11/2018
2	Interleukin-33IBA 12/2018 - 01/2018
2	Pep-1 peptideIBA 01/2017 - 07/2015
2	CarrageenanIBA 01/2017 - 07/2015
2	Collagen Type II (Type II Collagen)IBA 10/2016 - 01/2010

Therapy/Procedure

33	Therapeutics 01/2024 - 12/2006
4	Artificial Respiration (Mechanical Ventilation) 07/2023 - 09/2013
3	Transplantation 01/2017 - 01/2009
2	Organ Transplantation 03/2024 - 07/2021
2	Cannula 07/2023 - 06/2022
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2023
2	Critical Care (Surgical Intensive Care) 12/2020 - 01/2020
2	Catheters 01/2017 - 09/2013